Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Oct 07, 2024

SELL
$306.88 - $380.0 $230,466 - $285,380
-751 Reduced 1.26%
58,649 $22.2 Million
Q4 2023

Feb 12, 2024

SELL
$306.88 - $380.0 $230,466 - $285,380
-751 Reduced 1.26%
58,649 $22.2 Million
Q3 2023

Oct 07, 2024

BUY
$315.92 - $397.36 $161,435 - $203,050
511 Added 0.87%
59,400 $18.9 Million
Q3 2023

Nov 13, 2023

BUY
$315.92 - $397.36 $161,435 - $203,050
511 Added 0.87%
59,400 $18.9 Million
Q2 2023

Oct 07, 2024

SELL
$346.15 - $392.09 $5.23 Million - $5.93 Million
-15,122 Reduced 20.43%
58,889 $22.6 Million
Q2 2023

Aug 14, 2023

SELL
$346.15 - $392.09 $5.23 Million - $5.93 Million
-15,122 Reduced 20.43%
58,889 $22.6 Million
Q1 2023

Oct 07, 2024

SELL
$323.56 - $373.36 $3.92 Million - $4.52 Million
-12,116 Reduced 14.07%
74,011 $27.6 Million
Q1 2023

May 12, 2023

SELL
$323.56 - $373.36 $3.92 Million - $4.52 Million
-12,116 Reduced 14.07%
74,011 $27.6 Million
Q4 2022

Oct 07, 2024

BUY
$248.67 - $334.17 $21.4 Million - $28.8 Million
86,127 New
86,127 $28.5 Million
Q4 2022

Feb 10, 2023

BUY
$248.67 - $334.17 $5.41 Million - $7.26 Million
21,739 Added 33.76%
86,127 $28.5 Million
Q3 2022

Nov 14, 2022

SELL
$263.81 - $337.27 $5.1 Million - $6.52 Million
-19,319 Reduced 23.08%
64,388 $17 Million
Q2 2022

Aug 12, 2022

BUY
$301.4 - $428.42 $1.98 Million - $2.82 Million
6,573 Added 8.52%
83,707 $26.2 Million
Q1 2022

May 13, 2022

BUY
$379.46 - $424.54 $4.5 Million - $5.04 Million
11,869 Added 18.19%
77,134 $32.2 Million
Q4 2021

Feb 11, 2022

SELL
$373.53 - $434.12 $23.2 Million - $26.9 Million
-62,000 Reduced 48.72%
65,265 $27.3 Million
Q3 2021

Nov 09, 2021

BUY
$396.76 - $455.92 $26.5 Million - $30.4 Million
66,770 Added 110.37%
127,265 $52.6 Million
Q2 2021

Aug 11, 2021

BUY
$372.36 - $412.07 $1.45 Million - $1.61 Million
3,902 Added 6.89%
60,495 $24 Million
Q1 2021

May 11, 2021

SELL
$357.26 - $392.57 $4.3 Million - $4.73 Million
-12,048 Reduced 17.55%
56,593 $21.7 Million
Q4 2020

Feb 09, 2021

SELL
$319.05 - $363.32 $623,104 - $709,563
-1,953 Reduced 2.77%
68,641 $24.9 Million
Q3 2020

Nov 12, 2020

SELL
$280.08 - $347.78 $752,014 - $933,789
-2,685 Reduced 3.66%
70,594 $23.8 Million
Q2 2020

Aug 14, 2020

SELL
$270.93 - $320.3 $4.3 Million - $5.08 Million
-15,856 Reduced 17.79%
73,279 $20.8 Million
Q1 2020

May 14, 2020

SELL
$243.44 - $359.98 $402,893 - $595,766
-1,655 Reduced 1.82%
89,135 $24.6 Million
Q4 2019

Feb 14, 2020

SELL
$281.18 - $322.05 $7.2 Million - $8.25 Million
-25,604 Reduced 22.0%
90,790 $29.2 Million
Q3 2019

Nov 14, 2019

SELL
$294.25 - $341.49 $21.4 Million - $24.8 Million
-72,733 Reduced 38.46%
116,394 $34.6 Million
Q2 2019

Aug 14, 2019

BUY
$279.29 - $336.89 $19.6 Million - $23.6 Million
70,021 Added 58.79%
189,127 $63.7 Million
Q1 2019

May 15, 2019

SELL
$246.18 - $297.25 $5.12 Million - $6.18 Million
-20,782 Reduced 14.86%
119,106 $35.3 Million
Q4 2018

Feb 14, 2019

SELL
$232.7 - $281.66 $31.6 Million - $38.2 Million
-135,677 Reduced 49.24%
139,888 $35.6 Million
Q3 2018

Nov 14, 2018

SELL
$236.3 - $277.15 $9.28 Million - $10.9 Million
-39,267 Reduced 12.47%
275,565 $76.4 Million
Q2 2018

Aug 14, 2018

BUY
$217.98 - $237.23 $4.64 Million - $5.05 Million
21,308 Added 7.26%
314,832 $74.1 Million
Q1 2018

May 15, 2018

BUY
$218.74 - $251.43 $21.2 Million - $24.4 Million
97,068 Added 49.41%
293,524 $67.2 Million
Q4 2017

Feb 14, 2018

BUY
$217.88 - $244.43 $369,524 - $414,553
1,696 Added 0.87%
196,456 $42.8 Million
Q3 2017

Nov 14, 2017

SELL
$231.6 - $253.39 $48.9 Million - $53.5 Million
-211,071 Reduced 52.01%
194,760 $46.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
405,831
405,831 $97.2 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.